CraniUS Therapeutics Secures $20M in Series B Funding | StartUp Health Insights: Week of Feb 3, 2026
StartUp Health community member CraniUS is a neurotechnology company developing an implantable platform to bypass the blood-brain barrier for long-term, programmable drug delivery. Other funding this week included massive global rounds across AI infrastructure, women’s health, insurance, clinical trials, and diagnostic tools, underscoring continued investor momentum worldwide.